Literature DB >> 10911817

Bronchodilators in cystic fibrosis.

P L Brand1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 10911817      PMCID： PMC1305882     

Source DB:  PubMed          Journal:  J R Soc Med        ISSN： 0141-0768            Impact factor:   5.344


× No keyword cloud information.
  15 in total

1.  Tracheal mucociliary transport in patients with cystic fibrosis and its stimulation by terbutaline.

Authors:  R E Wood; A Wanner; J Hirsch; P M Farrell
Journal:  Am Rev Respir Dis       Date:  1975-06

2.  Comparison of nebulized and intravenous terbutaline during exacerbations of pulmonary infection in patients with cystic fibrosis.

Authors:  M J Finnegan; D V Hughes; M E Hodson
Journal:  Eur Respir J       Date:  1992-10       Impact factor: 16.671

3.  Changes in airflow obstruction and oxygen saturation in response to exercise and bronchodilators in cystic fibrosis.

Authors:  P I Macfarlane; D Heaf
Journal:  Pediatr Pulmonol       Date:  1990

4.  A controlled trial of long-term bronchodilator therapy in cystic fibrosis.

Authors:  P A Eggleston; B J Rosenstein; C M Stackhouse; E D Mellits; R A Baumgardner
Journal:  Chest       Date:  1991-05       Impact factor: 9.410

5.  A placebo-controlled, double-blind trial of the long-term effects of albuterol administration in patients with cystic fibrosis.

Authors:  P König; J Poehler; G J Barbero
Journal:  Pediatr Pulmonol       Date:  1998-01

6.  Effects of standard and high doses of salmeterol on lung function of hospitalized patients with cystic fibrosis.

Authors:  N L Hordvik; P H Sammut; C G Judy; J L Colombo
Journal:  Pediatr Pulmonol       Date:  1999-01

7.  Reduced effect of inhaled beta 2-adrenergic agonists on lung mucociliary clearance in patients with cystic fibrosis.

Authors:  J Mortensen; A Hansen; M Falk; I K Nielsen; S Groth
Journal:  Chest       Date:  1993-03       Impact factor: 9.410

8.  A longitudinal study of bronchodilator responsiveness in cystic fibrosis.

Authors:  N L Hordvik; P König; D Morris; C Kreutz; G J Barbero
Journal:  Am Rev Respir Dis       Date:  1985-06

9.  Bronchial vagal tone and responsiveness to histamine, exercise and bronchodilators in adult patients with cystic fibrosis.

Authors:  E H van Haren; J W Lammers; J Festen; C L van Herwaarden
Journal:  Eur Respir J       Date:  1992-10       Impact factor: 16.671

10.  Airway obstruction and airway wall instability in cystic fibrosis: the isolated and combined effect of theophylline and sympathomimetics.

Authors:  E Eber; B Oberwaldner; M S Zach
Journal:  Pediatr Pulmonol       Date:  1988
View more
  11 in total

Review 1.  Asthma in cystic fibrosis.

Authors:  Ian M Balfour-Lynn
Journal:  J R Soc Med       Date:  2003       Impact factor: 5.344

Review 2.  "CF asthma": what is it and what do we do about it?

Authors:  I M Balfour-Lynn; J S Elborn
Journal:  Thorax       Date:  2002-08       Impact factor: 9.139

3.  Sweat chloride levels in asthma.

Authors:  Anirban Mandal; S K Kabra
Journal:  Indian J Pediatr       Date:  2014-12-28       Impact factor: 1.967

Review 4.  Asthma in Cystic Fibrosis: Definitions and Implications of This Overlap Syndrome.

Authors:  Chad R Marion; Manuel Izquierdo; Holly C Hanes; Christopher Barrios
Journal:  Curr Allergy Asthma Rep       Date:  2021-02-09       Impact factor: 4.806

Review 5.  Treatment of severe small airways disease in children with cystic fibrosis: alternatives to corticosteroids.

Authors:  Adam Jaffe; Ian M Balfour-Lynn
Journal:  Paediatr Drugs       Date:  2002       Impact factor: 3.022

Review 6.  Short-acting inhaled bronchodilators for cystic fibrosis.

Authors:  Sherie Smith; Nicola J Rowbotham; Christopher T Edwards
Journal:  Cochrane Database Syst Rev       Date:  2022-06-24

Review 7.  Physiotherapy in infants and young children with cystic fibrosis: current practice and future developments.

Authors:  Louise Lannefors; Brenda M Button; Maggie McIlwaine
Journal:  J R Soc Med       Date:  2004       Impact factor: 5.344

Review 8.  Treatment of Pulmonary Disease of Cystic Fibrosis: A Comprehensive Review.

Authors:  Rosa María Girón Moreno; Marta García-Clemente; Layla Diab-Cáceres; Adrián Martínez-Vergara; Miguel Ángel Martínez-García; Rosa Mar Gómez-Punter
Journal:  Antibiotics (Basel)       Date:  2021-04-23

9.  Exhaled breath condensate detects baseline reductions in chloride and increases in response to albuterol in cystic fibrosis patients.

Authors:  Courtney M Wheatley; Wayne J Morgan; Nicholas A Cassuto; William T Foxx-Lupo; Cori L Daines; Mary A Morgan; Hanna Phan; Eric M Snyder
Journal:  Clin Med Insights Circ Respir Pulm Med       Date:  2013-12-10

10.  Pulmonary function parameters and use of bronchodilators in patients with cystic fibrosis.

Authors:  Lucia Harumi Muramatu; Roberto Stirbulov; Wilma Carvalho Neves Forte
Journal:  J Bras Pneumol       Date:  2013 Jan-Feb       Impact factor: 2.624
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.